Walnut Creek, CA, United States of America

Robin McDaid Barbour

USPTO Granted Patents = 49 

 

Average Co-Inventor Count = 3.7

ph-index = 10

Forward Citations = 356(Granted Patents)


Location History:

  • Newark, CA (US) (2000 - 2010)
  • Walnut Creek, CA (US) (2010 - 2024)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
49 patents (USPTO):

Title: Contributions of Robin McDaid Barbour in Alzheimer’s Disease Research

Introduction: Robin McDaid Barbour, based in Walnut Creek, CA, is an accomplished inventor with 46 patents to his name. His innovative work primarily focuses on developing therapies for neurodegenerative conditions, particularly Alzheimer's disease.

Latest Patents: Among his latest contributions are significant innovations in tau immunotherapy. This invention revolves around antibodies that inhibit or delay tau-associated pathologies and the symptomatic deterioration that follows. Additionally, he has developed a multi-epitope vaccine aimed at treating Alzheimer's disease. This disclosure comprises peptide compositions combining an amyloid-beta (Aβ) peptide and a tau peptide. It details methods for treating or providing prophylaxis for Alzheimer's disease or related conditions characterized by beta-amyloid deposition. The methods include strategies to clear deposits, inhibit aggregation of the aforementioned peptides, block neuronal uptake, and inhibit the propagation of tau seeds in individuals who are at risk of developing Alzheimer's disease or other tau- and amyloid-beta-related conditions.

Career Highlights: Robin McDaid Barbour has made a remarkable impact in the pharmaceutical field through his work with notable companies. He has played key roles in Prothena Biosciences Limited and Elan Pharmaceuticals, Inc., where he has contributed his expertise in developing groundbreaking therapeutic solutions.

Collaborations: Throughout his career, Barbour has collaborated with prominent researchers, including Tarlochan S Nijjar and Yue Liu. These partnerships have further propelled the advancement of research surrounding Alzheimer’s disease and related neurodegenerative disorders.

Conclusion: As a prolific inventor, Robin McDaid Barbour continues to contribute significantly to the understanding and treatment of Alzheimer's disease. His innovative patents and collaborations highlight a dedicated commitment to improving the lives of those affected by neurodegenerative conditions, solidifying his reputation as a leading inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…